AXIM (AXIM Biotechnologies) Total Operating Expense: $0.29 Mil (TTM As of Jun. 2025)


What is AXIM Biotechnologies Total Operating Expense?

AXIM Biotechnologies AXIM Total Operating Expense is $0.29 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's Total Operating Expense for the three months ended in Jun. 2025 was $0.02 Mil. AXIM Biotechnologies's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2025 was $0.29 Mil.

AXIM Biotechnologies Total Operating Expense Related Terms

AXIM Biotechnologies Total Operating Expense Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Total Operating Expense Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.83 7.79 4.66 2.79 1.83

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.59 0.00 0.27 0.02

AXIM Biotechnologies Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.29 Mil mean?
AXIM Biotechnologies (AXIM) has a Total Operating Expense of $0.29 Mil as of Jun. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' Total Operating Expense too high?
AXIM Biotechnologies' current Total Operating Expense is $0.29 Mil.
How does AXIM Biotechnologies' Total Operating Expense compare to HEPA and SCNI?
AXIM Biotechnologies' Total Operating Expense of $0.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Total Operating Expense is $0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Total Operating Expense of $0.29 Mil. The current Total Operating Expense is $0.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Total Operating Expense is $0.29 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.